MedTrace Logo

Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana

NCT01386801 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2013-09-06

No results posted yet for this study

Summary

Blood samples and health information (e.g., age at diagnosis, test results) are collected for the purposes of genetic research. The blood samples are assigned a number and stored in a repository for safe keeping until they are needed for a research project. Participants are persons who are healthy (not having high blood pressure, diabetes, or high cholesterol levels) or persons who have Diabetes Mellitus Type II(T2D) and live in Indiana. Participants complete a questionnaire at the time the blood sample is drawn. Visits are repeated at 2 and 5 years after initial contact. Researchers apply to the Fairbanks Institute for use of the blood samples and health information minus participant names and contact information. Their research is required to be related to find genes or substances made by genes that may be involved in Diabetes Mellitus Type II with the purpose of improving the investigators understanding of the illness potentially leading to the development of new diagnostic tools for identifying the illness, new treatments,or preventative measures.

Conditions

  • Diabetes Mellitus Type II

Sponsors & Collaborators

  • Indiana University School of Medicine

    collaborator OTHER

  • Richard M. Fairbanks Foundation

    collaborator OTHER

  • BioCrossroads

    collaborator OTHER

  • Regenstrief Institute, Inc.

    collaborator OTHER

  • Fairbanks Institute

    lead OTHER

Principal Investigators

  • Anantha Shekhar, MD · Indiana University School of Medine/CTSI

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2049-12-31
Completion
2050-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01386801 on ClinicalTrials.gov